Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market Research Methodology
Chapter 2. Executive Summary
2.1 Global Gut Microbiome Market, (2024 – 2033) (USD Million)
2.2 Global Gut Microbiome Market: snapshot
Chapter 3. Global Gut Microbiome Market – Industry Analysis
3.1 Gut Microbiome Market: Market Dynamics
3.2 Market Drivers
3.2.1 Increasing Awareness of Gut Health
3.2.2 Advancements in Microbiome Research
3.2.3 Expansion of Functional Food and Beverage Market
3.2.4 Healthcare Shift Towards Personalized Medicine
3.2.5 Expansion into New Therapeutic Areas.
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End User
Chapter 4. Global Gut Microbiome Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Gut Microbiome Market: Company Market Share, 2023
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Gut Microbiome Market – Product Type Analysis
5.1 Global Gut Microbiome Market Overview: By Product Type
5.1.1 Global Gut Microbiome Market Share, By Product Type, 2023 and 2033
5.2 Probiotics
5.2.1 Global Gut Microbiome Market by Probiotics, 2024 – 2033 (USD Million)
5.3 Prebiotics
5.3.1 Global Gut Microbiome Market by Prebiotics, 2024 – 2033 (USD Million)
5.4 Food supplements
5.4.1 Global Gut Microbiome Market by Food Supplements, 2024 – 2033 (USD Million)
5.5 Drugs and medications
5.5.1 Global Gut Microbiome Market by Drugs and Medications, 2024 – 2033 (USD Million)
5.6 Diagnostic kits and tools
5.6.1 Global Gut Microbiome Market by Diagnostic kits and tools, 2024 – 2033 (USD Million)
5.7 Others
5.7.1 Global Gut Microbiome Market by Others, 2024 – 2033 (USD Million)
Chapter 6. Global Gut Microbiome Market – Application Analysis
6.1 Global Gut Microbiome Market Overview: By Application
6.1.1 Global Gut Microbiome Market Share, By Application, 2023 and 2033
6.2 Digestive Health
6.2.1 Global Gut Microbiome Market by Digestive Health, 2024 – 2033 (USD Million)
6.3 Immune system support
6.3.1 Global Gut Microbiome Market by Immune System Support, 2024 – 2033 (USD Million)
6.4 Weight management
6.4.1 Global Gut Microbiome Market by Weight Management, 2024 – 2033 (USD Million)
6.5 Mental health and cognition
6.5.1 Global Gut Microbiome Market by Mental health and cognition, 2024 – 2033 (USD Million)
6.6 Skin health
6.6.1 Global Gut Microbiome Market by Skin Health, 2024 – 2033 (USD Million)
6.7 Others
6.7.1 Global Gut Microbiome Market by Others, 2024 – 2033 (USD Million)
Chapter 7. Global Gut Microbiome Market – End User Analysis
7.1 Global Gut Microbiome Market Overview: By End User
7.1.1 Global Gut Microbiome Market Share, By End User, 2023 and 2033
7.2 Healthcare providers
7.2.1 Global Gut Microbiome Market by Healthcare Providers, 2024 – 2033 (USD Million)
7.3 Food and beverage industry
7.3.1 Global Gut Microbiome Market by Food and Beverage Industry, 2024 – 2033 (USD Million)
7.4 Dietary supplement manufacturers
7.4.1 Global Gut Microbiome Market by Dietary Supplement Manufacturers, 2024 – 2033 (USD Million)
7.5 Research institutions
7.5.1 Global Gut Microbiome Market by Research Institutions, 2024 – 2033 (USD Million)
7.6 Direct-to-consumer
7.6.1 Global Gut Microbiome Market by Direct-to-consumer, 2024 – 2033 (USD Million)
7.7 Others
7.7.1 Global Gut Microbiome Market by Others, 2024 – 2033 (USD Million)
Chapter 8. Gut Microbiomes Market – Regional Analysis
8.1 Global Gut Microbiomes Market Regional Overview
8.2 Global Gut Microbiomes Market Share, by Region, 2023 & 2033 (USD Million)
8.3. North America
8.3.1 North America Gut Microbiomes Market, 2024 – 2033 (USD Million)
8.3.1.1 North America Gut Microbiomes Market, by Country, 2024 – 2033 (USD Million)
8.4 North America Gut Microbiomes Market, by Product Type, 2024 – 2033
8.4.1 North America Gut Microbiomes Market, by Product Type, 2024 – 2033 (USD Million)
8.5 North America Gut Microbiomes Market, by Application, 2024 – 2033
8.5.1 North America Gut Microbiomes Market, by Application, 2024 – 2033 (USD Million)
8.6 North America Gut Microbiomes Market, by End User, 2024 – 2033
8.6.1 North America Gut Microbiomes Market, by End User, 2024 – 2033 (USD Million)
8.7. Europe
8.7.1 Europe Gut Microbiomes Market, 2024 – 2033 (USD Million)
8.7.1.1 Europe Gut Microbiomes Market, by Country, 2024 – 2033 (USD Million)
8.8 Europe Gut Microbiomes Market, by Product Type, 2024 – 2033
8.8.1 Europe Gut Microbiomes Market, by Product Type, 2024 – 2033 (USD Million)
8.9 Europe Gut Microbiomes Market, by Application, 2024 – 2033
8.9.1 Europe Gut Microbiomes Market, by Application, 2024 – 2033 (USD Million)
8.10 Europe Gut Microbiomes Market, by End User, 2024 – 2033
8.10.1 Europe Gut Microbiomes Market, by End User, 2024 – 2033 (USD Million)
8.11. Asia Pacific
8.11.1 Asia Pacific Gut Microbiomes Market, 2024 – 2033 (USD Million)
8.11.1.1 Asia Pacific Gut Microbiomes Market, by Country, 2024 – 2033 (USD Million)
8.12 Asia Pacific Gut Microbiomes Market, by Product Type, 2024 – 2033
8.12.1 Asia Pacific Gut Microbiomes Market, by Product Type, 2024 – 2033 (USD Million)
8.13 Asia Pacific Gut Microbiomes Market, by Application, 2024 – 2033
8.13.1 Asia Pacific Gut Microbiomes Market, by Application, 2024 – 2033 (USD Million)
8.14 Asia Pacific Gut Microbiomes Market, by End User, 2024 – 2033
8.14.1 Asia Pacific Gut Microbiomes Market, by End User, 2024 – 2033 (USD Million)
8.15. Latin America
8.15.1 Latin America Gut Microbiomes Market, 2024 – 2033 (USD Million)
8.15.1.1 Latin America Gut Microbiomes Market, by Country, 2024 – 2033 (USD Million)
8.16 Latin America Gut Microbiomes Market, by Product Type, 2024 – 2033
8.16.1 Latin America Gut Microbiomes Market, by Product Type, 2024 – 2033 (USD Million)
8.17 Latin America Gut Microbiomes Market, by Application, 2024 – 2033
8.17.1 Latin America Gut Microbiomes Market, by Application, 2024 – 2033 (USD Million)
8.18 Latin America Gut Microbiomes Market, by End User, 2024 – 2033
8.18.1 Latin America Gut Microbiomes Market, by End User, 2024 – 2033 (USD Million)
8.19. The Middle-East and Africa
8.19.1 The Middle-East and Africa Gut Microbiomes Market, 2024 – 2033 (USD Million)
8.19.1.1 The Middle-East and Africa Gut Microbiomes Market, by Country, 2024 – 2033 (USD Million)
8.20 The Middle-East and Africa Gut Microbiomes Market, by Product Type, 2024 – 2033
8.20.1 The Middle-East and Africa Gut Microbiomes Market, by Product Type, 2024 – 2033 (USD Million)
8.21 The Middle-East and Africa Gut Microbiomes Market, by Application, 2024 – 2033
8.21.1 The Middle-East and Africa Gut Microbiomes Market, by Application, 2024 – 2033 (USD Million)
8.22 The Middle-East and Africa Gut Microbiomes Market, by End User, 2024 – 2033
8.22.1 The Middle-East and Africa Gut Microbiomes Market, by End User, 2024 – 2033 (USD Million)
Chapter 9. Company Profiles
9.1 DuPont de Nemours Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Yakult Honsha Co. Ltd.
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Nestlé Health Science
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 BioGaia AB
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Chr. Hansen Holding A/S
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Procter & Gamble Company
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 Bayer AG
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Pfizer Inc.
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 Johnson & Johnson
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 Novartis International AG
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments
9.11 Abbott Laboratories
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Business Strategy
9.11.5 Recent Developments
9.12 Kerry Group plc
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Business Strategy
9.12.5 Recent Developments
9.13 DSM Nutritional Products AG
9.13.1 Overview
9.13.2 Financials
9.13.3 Product Portfolio
9.13.4 Business Strategy
9.13.5 Recent Developments
9.14 ADM Protexin Ltd.
9.14.1 Overview
9.14.2 Financials
9.14.3 Product Portfolio
9.14.4 Business Strategy
9.14.5 Recent Developments
9.15 Danone S.A.
9.15.1 Overview
9.15.2 Financials
9.15.3 Product Portfolio
9.15.4 Business Strategy
9.15.5 Recent Developments
9.16 Others.
9.16.1 Overview
9.16.2 Financials
9.16.3 Product Portfolio
9.16.4 Business Strategy
9.16.5 Recent Developments
.jpg.jpg)